Core Insights - The article discusses the growth and potential of the sports regenerative medicine medical device market, driven by increasing demand for treatment and rehabilitation of sports injuries and degenerative diseases [1][5][12]. Group 1: Market Overview - The global sports regenerative medicine medical device market is projected to reach $900 million by 2024, with a compound annual growth rate (CAGR) of 33.3% from 2018 to 2024 [1][10]. - The Chinese market for sports regenerative medicine medical devices is expected to grow from 100 million yuan in 2020 to 800 million yuan in 2024, accounting for 14.8% of the total sports medicine market [1][10]. - The overall sports medicine market in China is anticipated to expand from 3.7 billion yuan in 2018 to 5.4 billion yuan in 2024, with a CAGR of 6.5% [8]. Group 2: Development Drivers - The "National Fitness" trend has led to an increase in the number of people participating in sports, with over 38.5% of the population engaging in regular exercise by 2024, up 4.6 percentage points from 2014 [5][6]. - The rising prevalence of degenerative diseases, such as osteoarthritis and chronic tendon injuries, is driving the demand for sports regenerative medicine medical devices [6][12]. - The aging population in China is significant, with 220 million people aged 65 and above by the end of 2024, representing 15.64% of the total population [6][7]. Group 3: Industry Trends - Domestic companies are actively investing in the sports regenerative medicine medical device sector, with several firms securing financing to enhance product development and market presence [10][11]. - The integration of advanced biomaterials and established tissue engineering technologies is improving the healing potential for soft tissue injuries and degenerative conditions [10][12]. - The market is expected to continue expanding, with projections indicating that the Chinese sports regenerative medicine medical device market could reach 3.4 billion yuan by 2030, with a CAGR of 27.3% from 2024 to 2030 [12][13].